• Long-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Hungary Italy Poland
  • Study Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Hungary +4
  • Study on the Effects of Somapacitan and Somatropin in Children with Short Stature Born Small for Gestational Age Without Catch-Up Growth by Age 2

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Hungary Italy Latvia
  • Study on the Effect of Ropivacaine on Breathing After Heart Surgery for Patients Undergoing Cardiac Surgery

    Not recruiting

    3 1 1 1
    Investigated drugs:
    France
  • Study on the Safety and Effectiveness of Lurbinectedin and Dostarlimab for Patients with Advanced Endometrial Cancer After Platinum-based Chemotherapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Spain
  • Study on the Effects of Oxygen Therapy with Vedolizumab, Ustekinumab, or Infliximab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Poland
  • Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Germany Italy The Netherlands +1
  • Study Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Bulgaria Croatia Poland Slovakia
  • Study on the Effects of Inebilizumab for Adults with Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain

powered by